Skip to content
Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and profit are unchanged.

Aerial view of the Zgounder processing plant in Morocco, with tanks, conveyors and the Aya Gold & Silver logo on a shed roof, mountains behind
Photo: Aya Gold & Silver

Aya Gold & Silver has refiled the management's discussion and analysis for its third quarter after finding that silver on its way to the refiner had been subtracted twice when it counted ounces sold. The fix adds 149,386 ounces to sales at its Zgounder mine in Morocco and cuts consolidated cash costs to $14.28 per silver equivalent ounce from $15.51, the company said on Monday 16 November. Revenue, profit and cash flow are unchanged.

Aya's corrected third quarter

  • 1,392,478 oz silver sold at Zgounder, up from 1,243,092 oz first reported
  • $14.28 consolidated cash cost per silver equivalent ounce sold, down from $15.51
  • $61.89 average realised silver price at Zgounder, down from $69.32

An ounce-counting error, not a money error

Aya, listed in Toronto and on Nasdaq under the ticker AYA, published its third-quarter results on Thursday 12 November. Four days later it filed an amended management's discussion and analysis (MD&A), the narrative report that sits beside the accounts and explains them. The new version replaces the original, and the company said the amended figures also override those in its 12 November results release. All figures are in US dollars.

The mistake is easy to describe. At the end of September some Zgounder silver was in transit to the refiner and still held in inventory. When Aya worked out how many ounces it had sold in the quarter, that silver was deducted twice, the company said. Sales were understated by 149,386 ounces.

What stayed put matters as much as what moved. Aya said revenue, cost of sales, net income, earnings per share, cash flows and its financial position are all unchanged. Its interim financial statements were not changed or refiled, and ounces produced and inventory quantities stand as first reported.

So the quarter's headline money figures are where they were on 12 November: revenue of $103.3m, up 90% on a year earlier, net income of $35.0m, operating cash flow of $48.1m and $183.8m of cash and cash equivalents at the end of September.

Aerial view of the Zgounder open pit, with benched walls, excavators loading haul trucks and a dirt haul road.
Aerial view of the Zgounder open pit, with benched walls, excavators loading haul trucks and a dirt haul road. Photo: Aya Gold & Silver
Gold in the three months to 16 November 2026. Daily closing prices from exchange data.
Gold in the three months to 16 November 2026. Daily closing prices from exchange data.

Why every per-ounce figure moves

Two of the measures mining investors watch most closely have ounces sold at the bottom of the fraction. Cash cost per ounce spreads the cost of producing the metal over the ounces sold. The average realised price is revenue divided by ounces sold. Aya calls its cash cost figures non-GAAP ratios: its own measures, with no standard definition under accounting rules.

Raise the ounce count while costs and revenue stay fixed, and both ratios fall.

Third quarter 2026As amendedAs first reported
Zgounder silver sold (oz)1,392,4781,243,092
Consolidated silver equivalent sold (oz)1,885,4101,736,024
Zgounder realised silver price ($/oz)61.8969.32
Consolidated realised price ($/oz silver equivalent)54.7859.50
Zgounder cash cost ($/oz silver sold)15.6517.53
Consolidated cash cost ($/oz silver equivalent sold)14.2815.51

Silver equivalent ounces combine Zgounder's silver with the gold and silver from Aya's Boumadine pyrite reclaim operation, where it is selling material from a historic stockpile, in a single silver-based count. The correction touches only Zgounder's silver, but Zgounder accounts for roughly three-quarters of the ounces sold in the quarter, so the consolidated figures move too.

For the first nine months of 2026, Zgounder silver sold rises to 4,090,992 ounces from 3,941,606. Consolidated cash costs for the period fall to $16.30 per silver equivalent ounce from $16.82, and Zgounder's to $17.32 from $17.97.

Costs look lower, and so does the price Aya received

On costs, the quarter looks better than first reported. Aya's original release put the fall in consolidated cash costs at 25% on a year earlier. Against the $20.79 an ounce reported for the third quarter of 2025, the corrected $14.28 is about 31% lower, on BMK News's arithmetic. Zgounder's corrected $15.65 is about 25% below the same $20.79, against the 16% fall first reported.

On price, the picture is weaker. The original release had Zgounder's realised silver price edging up 2% from the second quarter's $68.29. The corrected $61.89 is about 9% below it. Volumes swing the other way: Zgounder silver sold, first shown 6% lower than in the second quarter, is now about 5% higher.

What changes and what does not

  • Ounces sold, realised prices and cash costs per ounce are corrected for the third quarter and the first nine months.
  • Revenue, cost of sales, net income, earnings per share and cash flows are unchanged.
  • The interim financial statements were not refiled.
  • Ounces produced and inventory quantities stand as first reported.

The production record and guidance stand

Aya's output is unaffected. The company reported consolidated production of 2.0 million silver equivalent ounces in the quarter, including 1,497,749 ounces of silver from Zgounder, and called it a record. Its 12 November release narrowed Zgounder's 2026 production guidance to 5.6 to 5.8 million ounces, raising the low end from 5.2 million, and said full-year cash costs at Zgounder were expected to stay below its guidance of $21.50 an ounce. The correction notice does not mention guidance.

BMK News's earlier report on the results used the figures as first published. The corrected figures above replace them.

Aya Gold & Silver: share price, chart and news

Questions and answers

Why did Aya Gold & Silver amend its Q3 2026 MD&A?

Silver in transit to the refiner at the end of September, which was still held in inventory, was deducted twice when Aya calculated ounces sold at its Zgounder mine. The amended MD&A adds 149,386 ounces to third-quarter sales.

Did Aya Gold & Silver's revenue or profit change?

No. Aya said revenue, cost of sales, net income, earnings per share, cash flows and its financial position are unchanged, and its interim financial statements were not refiled.

What are Aya's corrected Q3 2026 cash costs?

Consolidated cash costs are $14.28 per silver equivalent ounce sold, down from $15.51 first reported. Cash costs at Zgounder are $15.65 per silver ounce sold, down from $17.53.

Sources

Related stories

Markets

Aya Gold & Silver Posts Record Q3 Output as Cash Costs Fall 25%

Aya Gold & Silver produced a record 2.03 million silver-equivalent ounces in Q3 2026, lifted revenue 90% to $103.3 million and cut consolidated cash costs to $15.51 an ounce.

Investing

Aya Gold & Silver: Investor Profile of the Moroccan Silver Miner and Its Boumadine Project

Aya Gold & Silver runs the Zgounder silver mine in Morocco and is studying a much larger gold-silver project at Boumadine. Its assets, latest numbers, cash position, risks and…

Investing

K92 Mining Builds Record $355.4m Net Cash as a $90.3m Tax Charge Brings a Q3 Loss

K92 Mining built a record $355.4m of net cash in the third quarter, but a $90.3m non-cash withholding tax charge turned $52.5m of adjusted earnings into a $39.5m net loss.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…

Investing

Warren Buffett Gives 9.2 Million Berkshire Shares to Four Family Foundations at Thanksgiving

Warren Buffett, 96, is giving 9,225,000 Berkshire B shares to four family foundations, over three times last year's gift, and says his confidence in Berkshire is as strong as ever.